Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)

Alix E. Seif, MD, Yimei Li, PhD, Viviane C. Cahen, Yuan-Shung V. Huang, MS, Matt Hall, PhD, E. Anders Kolb, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD, Kelly D Getz

Blood (2019) 134 (Supplement_1): 3496.

https://doi.org/10.1182/blood-2019-122887

Published: 2019

Journal Articles

A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort

Viviane C. Cahen, Yimei Li, PhD, Evanette Burrows, MPH, Caitlin W Elgarten, MD, Amanda M. DiNofia, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Yuan-Shung V. Huang, MS, Julie C Fitzgerald, MD, M. Monica Gramatges, MD PhD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Kelly D Getz, PhD, Richard Aplenc, MD PhD, Alix E. Seif, MD

Blood (2018) 132 (Supplement 1): 3597.

https://doi.org/10.1182/blood-2018-99-114235

Published: 2018

Journal Articles

Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)

Andrea Sitlinger, MD, Rishi Sachdev, David Anderson, BS/MS, S. Yousuf Zafar, MD MHS

Blood (2017) 130 (Supplement 1): 4680.

https://doi.org/10.1182/blood.V130.Suppl_1.4680.4680

Published: 2017

Journal Articles

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Samuel A. Merrill, MD PhD, Rakhi P. Naik, MD, Evan M Braunstein, MDPhD, Michael B. Streiff, Satish Shanbhag, MD, Sophie Lanzkron, MD, Alison R. Moliterno, MD, Robert A. Brodsky, MD

Blood (2017) 130 (Supplement 1): 677.

https://doi.org/10.1182/blood.V130.Suppl_1.677.221

Published: 2017

Journal Articles

Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation

Jonathan Wang, MASc, Andre C. Schuh, MD FRCPC, Deanna Wu, MBA, Christopher N. Bredeson, MD MSc, FRCPC, Jacinta Meharchand, MD FRCPC, Lisa Favell, MBA, Louis Fu, MISt, Kelly J. Woltman, MA, C. Tom Kouroukis, MDMSc,FRCPC

Blood (2017) 130 (Supplement 1): 3397.

https://doi.org/10.1182/blood.V130.Suppl_1.3397.3397

Published: 2017

Journal Articles

Patient Characteristics and Treatment Patterns in Elderly Patients Newly Diagnosed with Acute Lymphoblastic Leukemia (ALL) Using 100% Medicare ALL Data

Shuling Li, PhD, Julia T Molony, MS, Victoria Chia, PhD MPH, Aaron Jacob Katz, PharmD, PhD

Blood (2016) 128 (22): 3981.

https://doi.org/10.1182/blood.V128.22.3981.3981

Published: 2016

Journal Articles

External Validation of a Risk Assesment Model for Bleeding Risk in Medical Patients: Findings from the Improve Investigators in a Tertiary Health System

Annie Press, David Rosenberg, MD MPH, Joanna Fishbein, Franak Batliwalla, MPH, Alex C. Spyropoulos, MD

Blood (2015) 126 (23): 748.

https://doi.org/10.1182/blood.V126.23.748.748

Published: 2015

Journal Articles

Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group

Amanda M. DiNofia, MD, Alix E. Seif, MD MPH, Meenakshi Devidas, PhD, Yimei Li, PhD, Matthew Hall, PhD, Yuan-Shung Vera Huang, MS, Rochelle Bagatell, MD, William L. Carroll, MD, Naomi J. Winick, MD, Stephen P. Hunger, MD, Brian T. Fisher, DO, MSCE, Eric C. Larsen, MD, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 210.

https://doi.org/10.1182/blood.V124.21.210.210

Published: 2014

Journal Articles

Blood, Esa’s and Costs

Dialina Brilhante, MD, Ana Macedo, Ana Harfouche

Blood (2008) 112 (11): 1303.

https://doi.org/10.1182/blood.V112.11.1303.1303

Published: 2008

Journal Articles

Pharmacoeconomic Evaluation of Hypomethylating Agents Used for the Treatment of MDS

Bruce Feinberg, James Gilmore, Sally Haislip, Carlos M. Franco, MD, Tom Gondesen, Mansoor N. Saleh, MD

Blood (2008) 112 (11): 2380.

https://doi.org/10.1182/blood.V112.11.2380.2380

Published: 2008

Journal Articles

Celebrate hematology

Kenneth Kaushansky, MD

Blood (2002) 100 (13): 4257–4258.

https://doi.org/10.1182/blood-2002-09-2984

Published: 2002

NARROW

Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)

A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort

Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation

Patient Characteristics and Treatment Patterns in Elderly Patients Newly Diagnosed with Acute Lymphoblastic Leukemia (ALL) Using 100% Medicare ALL Data

External Validation of a Risk Assesment Model for Bleeding Risk in Medical Patients: Findings from the Improve Investigators in a Tertiary Health System

Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group

Blood, Esa’s and Costs

Pharmacoeconomic Evaluation of Hypomethylating Agents Used for the Treatment of MDS

Celebrate hematology

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only